Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Pharma & Healthcare > Met-Enkephalin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Met-Enkephalin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Pharma & Healthcare

Published: 2025-02-07

Pages: 102 Pages

Report ld: 3669902

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Met-Enkephalin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Met-enkephalin, also known as metenkefalin (INN), sometimes referred to as opioid growth factor (OGF),is a naturally occurring, endogenous opioid peptide that has opioid effects of a relatively short duration. It is one of the two forms of enkephalin, the other being leu-enkephalin. The enkephalins are considered to be the primary endogenous ligands of the δ-opioid receptor, due to their high potency and selectivity for the site over the other endogenous opioids.

North American market for Met-Enkephalin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Met-Enkephalin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Met-Enkephalin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Met-Enkephalin include Neuromics, Cayman Chemical, Genscript, Thermo Scientific, Abcam, Aapptec, Abbiotec, Bachem, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Met-Enkephalin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Met-Enkephalin by region & country, by Type, and by Application.

The Met-Enkephalin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Met-Enkephalin.

Market Segmentation

Report Metric
Details
Report Title
Met-Enkephalin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Market Size Available for Years
2025-2031
Global Met-Enkephalin Companies Covered
Neuromics
Cayman Chemical
Genscript
Thermo Scientific
Abcam
Aapptec
Abbiotec
Bachem
Global Met-Enkephalin Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Met-Enkephalin Market, Segment by Type
Human
Mouse
Rat
Rabbit
Global Met-Enkephalin Market, Segment by Application
Scientific Research
Medical
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Met-Enkephalin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Met-Enkephalin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Met-Enkephalin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Met-Enkephalin Product Introduction
    1.2 Global Met-Enkephalin Market Size Forecast
        1.2.1 Global Met-Enkephalin Sales Value (2020-2031)
        1.2.2 Global Met-Enkephalin Sales Volume (2020-2031)
        1.2.3 Global Met-Enkephalin Sales Price (2020-2031)
    1.3 Met-Enkephalin Market Trends & Drivers
        1.3.1 Met-Enkephalin Industry Trends
        1.3.2 Met-Enkephalin Market Drivers & Opportunity
        1.3.3 Met-Enkephalin Market Challenges
        1.3.4 Met-Enkephalin Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Met-Enkephalin Players Revenue Ranking (2024)
    2.2 Global Met-Enkephalin Revenue by Company (2020-2025)
    2.3 Global Met-Enkephalin Players Sales Volume Ranking (2024)
    2.4 Global Met-Enkephalin Sales Volume by Company Players (2020-2025)
    2.5 Global Met-Enkephalin Average Price by Company (2020-2025)
    2.6 Key Manufacturers Met-Enkephalin Manufacturing Base and Headquarters
    2.7 Key Manufacturers Met-Enkephalin Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Met-Enkephalin
    2.9 Met-Enkephalin Market Competitive Analysis
        2.9.1 Met-Enkephalin Market Concentration Rate (2020-2025)
        2.9.2 Global 5 and 10 Largest Manufacturers by Met-Enkephalin Revenue in 2024
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Met-Enkephalin as of 2024)
    2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Human
        3.1.2 Mouse
        3.1.3 Rat
        3.1.4 Rabbit
    3.2 Global Met-Enkephalin Sales Value by Type
        3.2.1 Global Met-Enkephalin Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Met-Enkephalin Sales Value, by Type (2020-2031)
        3.2.3 Global Met-Enkephalin Sales Value, by Type (%) (2020-2031)
    3.3 Global Met-Enkephalin Sales Volume by Type
        3.3.1 Global Met-Enkephalin Sales Volume by Type (2020 VS 2024 VS 2031)
        3.3.2 Global Met-Enkephalin Sales Volume, by Type (2020-2031)
        3.3.3 Global Met-Enkephalin Sales Volume, by Type (%) (2020-2031)
    3.4 Global Met-Enkephalin Average Price by Type (2020-2031)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Scientific Research
        4.1.2 Medical
        4.1.3 Others
    4.2 Global Met-Enkephalin Sales Value by Application
        4.2.1 Global Met-Enkephalin Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Met-Enkephalin Sales Value, by Application (2020-2031)
        4.2.3 Global Met-Enkephalin Sales Value, by Application (%) (2020-2031)
    4.3 Global Met-Enkephalin Sales Volume by Application
        4.3.1 Global Met-Enkephalin Sales Volume by Application (2020 VS 2024 VS 2031)
        4.3.2 Global Met-Enkephalin Sales Volume, by Application (2020-2031)
        4.3.3 Global Met-Enkephalin Sales Volume, by Application (%) (2020-2031)
    4.4 Global Met-Enkephalin Average Price by Application (2020-2031)

5 Segmentation by Region
    5.1 Global Met-Enkephalin Sales Value by Region
        5.1.1 Global Met-Enkephalin Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Met-Enkephalin Sales Value by Region (2020-2025)
        5.1.3 Global Met-Enkephalin Sales Value by Region (2026-2031)
        5.1.4 Global Met-Enkephalin Sales Value by Region (%), (2020-2031)
    5.2 Global Met-Enkephalin Sales Volume by Region
        5.2.1 Global Met-Enkephalin Sales Volume by Region: 2020 VS 2024 VS 2031
        5.2.2 Global Met-Enkephalin Sales Volume by Region (2020-2025)
        5.2.3 Global Met-Enkephalin Sales Volume by Region (2026-2031)
        5.2.4 Global Met-Enkephalin Sales Volume by Region (%), (2020-2031)
    5.3 Global Met-Enkephalin Average Price by Region (2020-2031)
    5.4 North America
        5.4.1 North America Met-Enkephalin Sales Value, 2020-2031
        5.4.2 North America Met-Enkephalin Sales Value by Country (%), 2024 VS 2031
    5.5 Europe
        5.5.1 Europe Met-Enkephalin Sales Value, 2020-2031
        5.5.2 Europe Met-Enkephalin Sales Value by Country (%), 2024 VS 2031
    5.6 Asia Pacific
        5.6.1 Asia Pacific Met-Enkephalin Sales Value, 2020-2031
        5.6.2 Asia Pacific Met-Enkephalin Sales Value by Region (%), 2024 VS 2031
    5.7 South America
        5.7.1 South America Met-Enkephalin Sales Value, 2020-2031
        5.7.2 South America Met-Enkephalin Sales Value by Country (%), 2024 VS 2031
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Met-Enkephalin Sales Value, 2020-2031
        5.8.2 Middle East & Africa Met-Enkephalin Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Met-Enkephalin Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Met-Enkephalin Sales Value
        6.2.1 Key Countries/Regions Met-Enkephalin Sales Value, 2020-2031
        6.2.2 Key Countries/Regions Met-Enkephalin Sales Volume, 2020-2031
    6.3 United States
        6.3.1 United States Met-Enkephalin Sales Value, 2020-2031
        6.3.2 United States Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Met-Enkephalin Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Met-Enkephalin Sales Value, 2020-2031
        6.4.2 Europe Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Met-Enkephalin Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Met-Enkephalin Sales Value, 2020-2031
        6.5.2 China Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Met-Enkephalin Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Met-Enkephalin Sales Value, 2020-2031
        6.6.2 Japan Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Met-Enkephalin Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Met-Enkephalin Sales Value, 2020-2031
        6.7.2 South Korea Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Met-Enkephalin Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Met-Enkephalin Sales Value, 2020-2031
        6.8.2 Southeast Asia Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Met-Enkephalin Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Met-Enkephalin Sales Value, 2020-2031
        6.9.2 India Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Met-Enkephalin Sales Value by Application, 2024 VS 2031

7 Company Profiles
    7.1 Neuromics
        7.1.1 Neuromics Company Information
        7.1.2 Neuromics Introduction and Business Overview
        7.1.3 Neuromics Met-Enkephalin Sales, Revenue, Price and Gross Margin (2020-2025)
        7.1.4 Neuromics Met-Enkephalin Product Offerings
        7.1.5 Neuromics Recent Development
    7.2 Cayman Chemical
        7.2.1 Cayman Chemical Company Information
        7.2.2 Cayman Chemical Introduction and Business Overview
        7.2.3 Cayman Chemical Met-Enkephalin Sales, Revenue, Price and Gross Margin (2020-2025)
        7.2.4 Cayman Chemical Met-Enkephalin Product Offerings
        7.2.5 Cayman Chemical Recent Development
    7.3 Genscript
        7.3.1 Genscript Company Information
        7.3.2 Genscript Introduction and Business Overview
        7.3.3 Genscript Met-Enkephalin Sales, Revenue, Price and Gross Margin (2020-2025)
        7.3.4 Genscript Met-Enkephalin Product Offerings
        7.3.5 Genscript Recent Development
    7.4 Thermo Scientific
        7.4.1 Thermo Scientific Company Information
        7.4.2 Thermo Scientific Introduction and Business Overview
        7.4.3 Thermo Scientific Met-Enkephalin Sales, Revenue, Price and Gross Margin (2020-2025)
        7.4.4 Thermo Scientific Met-Enkephalin Product Offerings
        7.4.5 Thermo Scientific Recent Development
    7.5 Abcam
        7.5.1 Abcam Company Information
        7.5.2 Abcam Introduction and Business Overview
        7.5.3 Abcam Met-Enkephalin Sales, Revenue, Price and Gross Margin (2020-2025)
        7.5.4 Abcam Met-Enkephalin Product Offerings
        7.5.5 Abcam Recent Development
    7.6 Aapptec
        7.6.1 Aapptec Company Information
        7.6.2 Aapptec Introduction and Business Overview
        7.6.3 Aapptec Met-Enkephalin Sales, Revenue, Price and Gross Margin (2020-2025)
        7.6.4 Aapptec Met-Enkephalin Product Offerings
        7.6.5 Aapptec Recent Development
    7.7 Abbiotec
        7.7.1 Abbiotec Company Information
        7.7.2 Abbiotec Introduction and Business Overview
        7.7.3 Abbiotec Met-Enkephalin Sales, Revenue, Price and Gross Margin (2020-2025)
        7.7.4 Abbiotec Met-Enkephalin Product Offerings
        7.7.5 Abbiotec Recent Development
    7.8 Bachem
        7.8.1 Bachem Company Information
        7.8.2 Bachem Introduction and Business Overview
        7.8.3 Bachem Met-Enkephalin Sales, Revenue, Price and Gross Margin (2020-2025)
        7.8.4 Bachem Met-Enkephalin Product Offerings
        7.8.5 Bachem Recent Development

8 Industry Chain Analysis
    8.1 Met-Enkephalin Industrial Chain
    8.2 Met-Enkephalin Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Met-Enkephalin Sales Model
        8.5.2 Sales Channel
        8.5.3 Met-Enkephalin Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Met-Enkephalin Market Trends
 Table 2. Met-Enkephalin Market Drivers & Opportunity
 Table 3. Met-Enkephalin Market Challenges
 Table 4. Met-Enkephalin Market Restraints
 Table 5. Global Met-Enkephalin Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Met-Enkephalin Revenue Market Share by Company (2020-2025)
 Table 7. Global Met-Enkephalin Sales Volume by Company (2020-2025) & (K Units)
 Table 8. Global Met-Enkephalin Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Met-Enkephalin Price by Company (2020-2025) & (US$/Unit)
 Table 10. Key Manufacturers Met-Enkephalin Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Met-Enkephalin Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Met-Enkephalin
 Table 13. Global Met-Enkephalin Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Met-Enkephalin as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Met-Enkephalin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Met-Enkephalin Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Met-Enkephalin Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Met-Enkephalin Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Met-Enkephalin Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Met-Enkephalin Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
 Table 22. Global Met-Enkephalin Sales Volume by Type (2020-2025) & (K Units)
 Table 23. Global Met-Enkephalin Sales Volume by Type (2026-2031) & (K Units)
 Table 24. Global Met-Enkephalin Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Met-Enkephalin Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Met-Enkephalin Price by Type (2020-2025) & (US$/Unit)
 Table 27. Global Met-Enkephalin Price by Type (2026-2031) & (US$/Unit)
 Table 28. Global Met-Enkephalin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Met-Enkephalin Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Met-Enkephalin Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Met-Enkephalin Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Met-Enkephalin Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Met-Enkephalin Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
 Table 34. Global Met-Enkephalin Sales Volume by Application (2020-2025) & (K Units)
 Table 35. Global Met-Enkephalin Sales Volume by Application (2026-2031) & (K Units)
 Table 36. Global Met-Enkephalin Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Met-Enkephalin Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Met-Enkephalin Price by Application (2020-2025) & (US$/Unit)
 Table 39. Global Met-Enkephalin Price by Application (2026-2031) & (US$/Unit)
 Table 40. Global Met-Enkephalin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Met-Enkephalin Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Met-Enkephalin Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Met-Enkephalin Sales Value by Region (2020-2025) & (%)
 Table 44. Global Met-Enkephalin Sales Value by Region (2026-2031) & (%)
 Table 45. Global Met-Enkephalin Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
 Table 46. Global Met-Enkephalin Sales Volume by Region (2020-2025) & (K Units)
 Table 47. Global Met-Enkephalin Sales Volume by Region (2026-2031) & (K Units)
 Table 48. Global Met-Enkephalin Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Met-Enkephalin Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Met-Enkephalin Average Price by Region (2020-2025) & (US$/Unit)
 Table 51. Global Met-Enkephalin Average Price by Region (2026-2031) & (US$/Unit)
 Table 52. Key Countries/Regions Met-Enkephalin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Met-Enkephalin Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Met-Enkephalin Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Met-Enkephalin Sales Volume, (2020-2025) & (K Units)
 Table 56. Key Countries/Regions Met-Enkephalin Sales Volume, (2026-2031) & (K Units)
 Table 57. Neuromics Company Information
 Table 58. Neuromics Introduction and Business Overview
 Table 59. Neuromics Met-Enkephalin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 60. Neuromics Met-Enkephalin Product Offerings
 Table 61. Neuromics Recent Development
 Table 62. Cayman Chemical Company Information
 Table 63. Cayman Chemical Introduction and Business Overview
 Table 64. Cayman Chemical Met-Enkephalin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 65. Cayman Chemical Met-Enkephalin Product Offerings
 Table 66. Cayman Chemical Recent Development
 Table 67. Genscript Company Information
 Table 68. Genscript Introduction and Business Overview
 Table 69. Genscript Met-Enkephalin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 70. Genscript Met-Enkephalin Product Offerings
 Table 71. Genscript Recent Development
 Table 72. Thermo Scientific Company Information
 Table 73. Thermo Scientific Introduction and Business Overview
 Table 74. Thermo Scientific Met-Enkephalin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Thermo Scientific Met-Enkephalin Product Offerings
 Table 76. Thermo Scientific Recent Development
 Table 77. Abcam Company Information
 Table 78. Abcam Introduction and Business Overview
 Table 79. Abcam Met-Enkephalin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Abcam Met-Enkephalin Product Offerings
 Table 81. Abcam Recent Development
 Table 82. Aapptec Company Information
 Table 83. Aapptec Introduction and Business Overview
 Table 84. Aapptec Met-Enkephalin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Aapptec Met-Enkephalin Product Offerings
 Table 86. Aapptec Recent Development
 Table 87. Abbiotec Company Information
 Table 88. Abbiotec Introduction and Business Overview
 Table 89. Abbiotec Met-Enkephalin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Abbiotec Met-Enkephalin Product Offerings
 Table 91. Abbiotec Recent Development
 Table 92. Bachem Company Information
 Table 93. Bachem Introduction and Business Overview
 Table 94. Bachem Met-Enkephalin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Bachem Met-Enkephalin Product Offerings
 Table 96. Bachem Recent Development
 Table 97. Key Raw Materials Lists
 Table 98. Raw Materials Key Suppliers Lists
 Table 99. Met-Enkephalin Downstream Customers
 Table 100. Met-Enkephalin Distributors List
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources


List of Figures
 Figure 1. Met-Enkephalin Product Picture
 Figure 2. Global Met-Enkephalin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Met-Enkephalin Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Met-Enkephalin Sales Volume (2020-2031) & (K Units)
 Figure 5. Global Met-Enkephalin Sales Price (2020-2031) & (US$/Unit)
 Figure 6. Met-Enkephalin Report Years Considered
 Figure 7. Global Met-Enkephalin Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Met-Enkephalin Players Sales Volume Ranking (2024) & (K Units)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Met-Enkephalin Revenue in 2024
 Figure 10. Met-Enkephalin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Human Picture
 Figure 12. Mouse Picture
 Figure 13. Rat Picture
 Figure 14. Rabbit Picture
 Figure 15. Global Met-Enkephalin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 16. Global Met-Enkephalin Sales Value Market Share by Type, 2024 & 2031
 Figure 17. Global Met-Enkephalin Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
 Figure 18. Global Met-Enkephalin Sales Volume Market Share by Type, 2024 & 2031
 Figure 19. Global Met-Enkephalin Price by Type (2020-2031) & (US$/Unit)
 Figure 20. Product Picture of Scientific Research
 Figure 21. Product Picture of Medical
 Figure 22. Product Picture of Others
 Figure 23. Global Met-Enkephalin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 24. Global Met-Enkephalin Sales Value Market Share by Application, 2024 & 2031
 Figure 25. Global Met-Enkephalin Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
 Figure 26. Global Met-Enkephalin Sales Volume Market Share by Application, 2024 & 2031
 Figure 27. Global Met-Enkephalin Price by Application (2020-2031) & (US$/Unit)
 Figure 28. North America Met-Enkephalin Sales Value (2020-2031) & (US$ Million)
 Figure 29. North America Met-Enkephalin Sales Value by Country (%), 2024 VS 2031
 Figure 30. Europe Met-Enkephalin Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Europe Met-Enkephalin Sales Value by Country (%), 2024 VS 2031
 Figure 32. Asia Pacific Met-Enkephalin Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Met-Enkephalin Sales Value by Region (%), 2024 VS 2031
 Figure 34. South America Met-Enkephalin Sales Value, (2020-2031) & (US$ Million)
 Figure 35. South America Met-Enkephalin Sales Value by Country (%), 2024 VS 2031
 Figure 36. Middle East & Africa Met-Enkephalin Sales Value, (2020-2031) & (US$ Million)
 Figure 37. Middle East & Africa Met-Enkephalin Sales Value by Country (%), 2024 VS 2031
 Figure 38. Key Countries/Regions Met-Enkephalin Sales Value (%), (2020-2031)
 Figure 39. Key Countries/Regions Met-Enkephalin Sales Volume (%), (2020-2031)
 Figure 40. United States Met-Enkephalin Sales Value, (2020-2031) & (US$ Million)
 Figure 41. United States Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
 Figure 42. United States Met-Enkephalin Sales Value by Application (%), 2024 VS 2031
 Figure 43. Europe Met-Enkephalin Sales Value, (2020-2031) & (US$ Million)
 Figure 44. Europe Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
 Figure 45. Europe Met-Enkephalin Sales Value by Application (%), 2024 VS 2031
 Figure 46. China Met-Enkephalin Sales Value, (2020-2031) & (US$ Million)
 Figure 47. China Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
 Figure 48. China Met-Enkephalin Sales Value by Application (%), 2024 VS 2031
 Figure 49. Japan Met-Enkephalin Sales Value, (2020-2031) & (US$ Million)
 Figure 50. Japan Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
 Figure 51. Japan Met-Enkephalin Sales Value by Application (%), 2024 VS 2031
 Figure 52. South Korea Met-Enkephalin Sales Value, (2020-2031) & (US$ Million)
 Figure 53. South Korea Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
 Figure 54. South Korea Met-Enkephalin Sales Value by Application (%), 2024 VS 2031
 Figure 55. Southeast Asia Met-Enkephalin Sales Value, (2020-2031) & (US$ Million)
 Figure 56. Southeast Asia Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
 Figure 57. Southeast Asia Met-Enkephalin Sales Value by Application (%), 2024 VS 2031
 Figure 58. India Met-Enkephalin Sales Value, (2020-2031) & (US$ Million)
 Figure 59. India Met-Enkephalin Sales Value by Type (%), 2024 VS 2031
 Figure 60. India Met-Enkephalin Sales Value by Application (%), 2024 VS 2031
 Figure 61. Met-Enkephalin Industrial Chain
 Figure 62. Met-Enkephalin Manufacturing Cost Structure
 Figure 63. Channels of Distribution (Direct Sales, and Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed

Description

The global market for Met-Enkephalin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Met-enkephalin, also known as metenkefalin (INN), sometimes referred to as opioid growth factor (OGF),is a naturally occurring, endogenous opioid peptide that has opioid effects of a relatively short duration. It is one of the two forms of enkephalin, the other being leu-enkephalin. The enkephalins are considered to be the primary endogenous ligands of the δ-opioid receptor, due to their high potency and selectivity for the site over the other endogenous opioids.

North American market for Met-Enkephalin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Met-Enkephalin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Met-Enkephalin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Market Segmentation

Related Reports

Global Met-Enkephalin Market Research Report 2024
Met-enkephalin, also known as metenkefalin (INN), sometimes referred to as opioid growth factor (OGF),is a naturally occurring, endogenous opioid peptide that has opioid effects of a relatively short duration. It is one of the two forms of enkephalin, the other being leu-enkephalin. The enkephalins are considered to be the primary endogenous ligands of the δ-opioid receptor, due to their high potency and selectivity for the site over the other endogenous opioids.
Published: 2024-01-17
Pages: 79
USD 2900.00
(Single User License)
Global Met-Enkephalin Market Insights, Forecast to 2030
Met-enkephalin, also known as metenkefalin (INN), sometimes referred to as opioid growth factor (OGF),is a naturally occurring, endogenous opioid peptide that has opioid effects of a relatively short duration. It is one of the two forms of enkephalin, the other being leu-enkephalin. The enkephalins are considered to be the primary endogenous ligands of the δ-opioid receptor, due to their high potency and selectivity for the site over the other endogenous opioids.
Published: 2024-04-12
Pages: 94
USD 4900.00
(Single User License)
Met-Enkephalin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Met-enkephalin, also known as metenkefalin (INN), sometimes referred to as opioid growth factor (OGF),is a naturally occurring, endogenous opioid peptide that has opioid effects of a relatively short duration. It is one of the two forms of enkephalin, the other being leu-enkephalin. The enkephalins are considered to be the primary endogenous ligands of the δ-opioid receptor, due to their high potency and selectivity for the site over the other endogenous opioids.
Published: 2024-01-10
Pages: 92
USD 3950.00
(Single User License)
Global Met-Enkephalin Market Research Report 2025
The global market for Met-Enkephalin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 86
USD 2900.00
(Single User License)

Global Met-Enkephalin Market Research Report 2024
Met-enkephalin, also known as metenkefalin (INN), sometimes referred to as opioid growth factor (OGF),is a naturally occurring, endogenous opioid peptide that has opioid effects of a relatively short duration. It is one of the two forms of enkephalin, the other being leu-enkephalin. The enkephalins are considered to be the primary endogenous ligands of the δ-opioid receptor, due to their high potency and selectivity for the site over the other endogenous opioids.
Published: 2024-01-17
Pages: 79
USD 2900.00 ()
Global Met-Enkephalin Market Insights, Forecast to 2030
Met-enkephalin, also known as metenkefalin (INN), sometimes referred to as opioid growth factor (OGF),is a naturally occurring, endogenous opioid peptide that has opioid effects of a relatively short duration. It is one of the two forms of enkephalin, the other being leu-enkephalin. The enkephalins are considered to be the primary endogenous ligands of the δ-opioid receptor, due to their high potency and selectivity for the site over the other endogenous opioids.
Published: 2024-04-12
Pages: 94
USD 4900.00 ()
Met-Enkephalin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Met-enkephalin, also known as metenkefalin (INN), sometimes referred to as opioid growth factor (OGF),is a naturally occurring, endogenous opioid peptide that has opioid effects of a relatively short duration. It is one of the two forms of enkephalin, the other being leu-enkephalin. The enkephalins are considered to be the primary endogenous ligands of the δ-opioid receptor, due to their high potency and selectivity for the site over the other endogenous opioids.
Published: 2024-01-10
Pages: 92
USD 3950.00 ()
Global Met-Enkephalin Market Research Report 2025
The global market for Met-Enkephalin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 86
USD 2900.00 ()